A detailed history of Sei Investments CO transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Sei Investments CO holds 17,060 shares of RCKT stock, worth $217,003. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,060
Holding current value
$217,003
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$17.6 - $25.88 $300,256 - $441,512
17,060 New
17,060 $315,000
Q4 2023

Feb 14, 2024

SELL
$16.78 - $31.94 $42,453 - $80,808
-2,530 Reduced 25.82%
7,268 $217,000
Q3 2023

Nov 14, 2023

BUY
$15.07 - $24.05 $147,655 - $235,641
9,798 New
9,798 $200,000
Q2 2021

Aug 06, 2021

SELL
$39.41 - $47.25 $512,211 - $614,108
-12,997 Closed
0 $0
Q4 2020

Feb 08, 2021

BUY
$23.3 - $59.57 $302,830 - $774,231
12,997 New
12,997 $713,000

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $963M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.